The UK’s National Institute for Health and Care Excellence has published a Medtech Innovation Briefing (MIB) regarding the use of V.A.C. VERAFLO™ Therapy for the treatment of chronic and acute infected wounds.
Based on the evidence evaluated for the MIB, it showed that V.A.C. VERAFLO Therapy - negative pressure wound therapy (NPWT) coupled with automated instillation – was shown to be more effective than standard of care, including moist wound care and traditional NPWT, in treating acutely infected or chronic non-healing wounds
Learn more: http://bit.ly/2uSfoYi
Please refer to the Instructions for Use for a complete list of indicated uses, contraindications, warnings and precautions: http://bit.ly/2NCFrt9